CIK: 0001887785
Total reported value
$22.1M
Reporting period: 2025-12-31 · Number of holdings: 3
Madrona Venture Group, LLC disclosed 3 holdings in its latest 13F filing for the period ending 2025-12-31, with total reported value of $22.1M and a quarterly turnover rate of 48.8%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "M"
Sector classification currently covers about 45% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Terms of Use for AI
AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/13f/madrona-venture-group-llc
Add NAUT
0.0% $6.7M
Trim PATH
0.0% $1.8M
Trim DNA
0.0% -$266.0K
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NAUT | Nautilus Biotechnology INC | Stock-Other | 53.24% | +16.48% | — | |
| 2 | PATH | Uipath INC - Class A | Stock-Tech | 45.16% | -13.60% | — | |
| 3 | DNA | Ginkgo Bioworks Holdings INC | Stock-Other | 1.60% | -2.87% | — |
Performance for Q3 2026
—
Performance Last 4 Quarters
+0.5%
Based on 45% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings | |
|---|---|---|---|---|---|
| 2025 Q4 | 3 | $22.1M | 49 | ||
| 2025 Q3 | 3 | $13.8M | 100 | ||
| 2025 Q2 | 3 | $12.6M | 0 | ||
| 2025 Q1 | 3 | $28.5M | 0 | ||
| 2024 Q4 | 4 | $53.8M | 0 | ||
| 2024 Q3 | 4 | $74.6M | 0 | ||
| 2024 Q2 | 4 | $93.7M | 0 | ||
| 2024 Q1 | 4 | $117.5M | 0 | ||
| 2023 Q4 | 6 | $427.1M | 0 | ||
| 2023 Q3 | 6 | $291.9M | 0 | ||
| 2023 Q2 | 5 | $274.6M | 0 | ||
| 2023 Q1 | 6 | $246.7M | 0 | ||
| 2022 Q4 | 5 | $207.5M | 0 | ||
| 2022 Q3 | 5 | $217.3M | 0 | ||
| 2022 Q2 | 5 | $215.4M | 0 | ||
| 2022 Q1 | 5 | $337.7M | 0 | ||
| 2021 Q4 | 4 | $529.4M | 0 | ||
| 2021 Q3 | 4 | $752.3M | 0 | ||
| 2021 Q2 | 3 | $617.4M | 0 | ||
| 2021 Q1 | 2 | $544.4M | 0 | ||
| 2020 Q4 | 2 | $741.5M | 0 |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | NAUT | Nautilus Biotechnology INC | +16.5% | — | Unchanged |
| 2 | DNA | Ginkgo Bioworks Holdings INC | -2.9% | — | Unchanged |
| 3 | PATH | Uipath INC - Class A | -13.6% | — | Unchanged |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2025 Q4 | 2026-02-13 | 13F-HR | View on EDGAR |
| 2025 Q3 | 2025-10-31 | 13F-HR | View on EDGAR |
| 2025 Q2 | 2025-08-11 | 13F-HR | View on EDGAR |
| 2025 Q1 | 2025-05-07 | 13F-HR | View on EDGAR |
| 2024 Q4 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024 Q3 | 2024-11-04 | 13F-HR | View on EDGAR |
| 2024 Q2 | 2024-07-25 | 13F-HR | View on EDGAR |
| 2024 Q1 | 2024-05-08 | 13F-HR | View on EDGAR |
| 2023 Q4 | 2024-01-30 | 13F-HR | View on EDGAR |
| 2023 Q3 | 2023-11-08 | 13F-HR | View on EDGAR |
| 2023 Q2 | 2023-08-03 | 13F-HR | View on EDGAR |
| 2023 Q1 | 2023-05-05 | 13F-HR | View on EDGAR |
| 2022 Q4 | 2023-05-05 | Amendment | View on EDGAR |
| 2022 Q4 | 2023-02-08 | 13F-HR | View on EDGAR |
| 2022 Q3 | 2023-05-05 | Amendment | View on EDGAR |
| 2022 Q3 | 2022-11-04 | 13F-HR | View on EDGAR |
| 2022 Q2 | 2023-05-05 | Amendment | View on EDGAR |
| 2022 Q2 | 2022-08-03 | 13F-HR | View on EDGAR |
| 2022 Q1 | 2023-05-05 | Amendment | View on EDGAR |
| 2022 Q1 | 2022-05-09 | 13F-HR | View on EDGAR |
| 2021 Q4 | 2022-02-11 | 13F-HR | View on EDGAR |
| 2021 Q3 | 2021-10-22 | 13F-HR | View on EDGAR |
| 2021 Q2 | 2021-10-15 | 13F-HR | View on EDGAR |
| 2021 Q1 | 2021-10-14 | 13F-HR | View on EDGAR |
| 2020 Q4 | 2021-10-13 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001844454
Total reported value
$22.0M
54 stks
2026-03-31
AUM within 0.3% of this institution
CIK 0001556970
Total reported value
$21.9M
66 stks
2017-06-30
Stale — no recent filing
AUM within 0.5% of this institution
CIK 0001389669
Total reported value
$21.9M
32 stks
2013-09-30
Stale — no recent filing
AUM within 0.6% of this institution
Access Madrona Venture Group, LLC's institutional profile programmatically:
REST API
curl https://alphasmo.com/api/v1/institutions/madrona-venture-group-llcCLI
npx alphasmo institutions get madrona-venture-group-llcFull API & MCP documentation →